Frigas 2007.
Methods | Prospective, double‐blind, placebo‐controlled trial |
Participants | 8 patients with chronic rhinosinusitis and mild asthma |
Interventions | Group 1: 200 mg of itraconazole, twice daily for 4 weeks; Group 2: placebo tablets, twice daily for 4 weeks |
Outcomes | Chronic rhinosinusitis symptoms, sinus CT scan |
Notes | Abstract only. Contacted authors for more information but no response was received. Abstract published in 2007; it is unlikely that this study will be published in full. |